Why are you trying to extend life?
Can I live longer while staying healthy?
Are you focusing only on people?
Are you trying to cure a specific disease?
What type of products are you working on?
What is unique about your approach?
What will be the price of your products?
Yes, science has demonstrated that we can slow down the ageing process and extend the lives of animals in the laboratory. Through our own research, we have extended the lifespan of many animals including yeast, worms, flies, fish, and mice. This gives us confidence to now pursue similar results for pets and for people.
Our society is ageing at an unprecedented rate, which makes ageing one of the most important challenges of our time. By extending life, EPITERNA intends to improve health and reduce the pain, suffering, and limitations that come with age-related chronic diseases; essentially creating more time that matters.
Yes, EPITERNA’s mission is to increase not only the number of years that people and their pets live, but also the quality of those years. By slowing down the ageing process, we intend not only to extend life, but also to delay the onset of age-related diseases and prevent the functional decline that comes with old age. Extending life also means living healthy for longer.
No, we are focusing on extending the healthy lifespan of any animal - starting with companion dogs, cats and people.
No, instead of trying to cure a specific disease, EPITERNA is focused on slowing down the process of ageing itself. This preventive approach will delay the onset of age-related chronic diseases and avoid much of the associated pain and suffering.
We develop medicines to slow down the process of ageing. EPITERNA is committed to scientific rigour, which means that all our products will undergo thorough clinical trials before their commercialisation to guarantee their safety and efficacy.
Instead of focusing on one mechanism or pathway involved in the ageing process, EPITERNA’s research platform is designed to identify, in a high-throughput manner, drugs and combinations that safely extend healthy lifespan across multiple species.
Ageing affects all pets and people, therefore EPITERNA is committed to developing products that are affordable and accessible to everyone regardless of social or economic background.
Safety is our top priority. This is why we are initially focused on medicines that are already approved and proven to be safe.
No, despite the scientific background of some of the members of our team, EPITERNA is not currently focused on epigenetic reprogramming.
We are not recruiting for our clinical trials at the moment, but we are eager to involve pets and people when the time comes. We will announce enrollment opportunities to participate in our clinical trials in the near future.